PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Echinacea polysaccharide alleviates LPS-induced lung injury via inhibiting inflammation, apoptosis and activation of the TLR4/NF-kappaB signal pathway.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 33182056 ↗2020Reported benefit

Echinacea polysaccharide alleviates LPS-induced lung injury via inhibiting inflammation, apoptosis and activation of the TLR4/NF-kappaB signal pathway.

MouseEndotoxin/LPSC57BL/65 mg/kg or 10 mg/kg in vivo; 100 micrograms/mL in RAW 264.7…Administered after lipopolysaccharide induction in vivo; in vitro cells pretrea…

Model: Acute lung injury induced with lipopolysaccharide 2.5 mg/kg

Echinacea polysaccharide reduced lipopolysaccharide-induced lung pathological damage, lung wet to dry weight ratio and myeloperoxidase activity, and lowered leukocyte, eosinophil, neutrophil, lymphocyte and macrophage counts in bronchoalveolar lavage fluid. It reduced TNF-alpha, IL-6 and IL-1beta i…

Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.